Introduction
Background
Obsessive-compulsive disorder (OCD) is a relatively common, if not always recognized, disorder that is often associated with significant distress and impairment in functioning. Due to stigma and lack of recognition, individuals with OCD often must wait many years before they receive a correct diagnosis and indicated treatment. In severe presentations, this disorder is quite disabling and is appropriately characterized as an example of severe and persistent mental illness.
OCD is classified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) as an anxiety disorder.1 It is characterized by distressing intrusive obsessive thoughts and/or repetitive compulsive actions (which may be physical or mental acts) that are clinically significant. The specific DSM-IV-TR criteria for OCD are as follows:
- The individual expresses either obsessions or compulsions. Obsessions are defined by the following 4 criteria.
- Recurrent and persistent thoughts, impulses, or images are experienced at some time during the disturbance as intrusive and inappropriate and cause marked anxiety and distress. Those with this disorder recognize the craziness of these unwanted thoughts (such as fears of hurting their children) and would not act on them, but the thoughts are very disturbing and difficult to tell others about.
- The thoughts, impulses, or images are not simply excessive worries about real-life problems.
- The person attempts to suppress or ignore such thoughts, impulses, or images or to neutralize them with some other thought or action.
- The person recognizes that the obsessional thoughts, impulses, or images are a product of his/her own mind (not imposed from without, as in thought insertion).
- Compulsions are defined by the following 2 criteria:
- The person performs repetitive behaviors (eg, hand washing, ordering, checking) or mental acts (eg, praying, counting, repeating words silently) in response to an obsession or according to rules that must be applied rigidly.
- The behaviors or mental acts are aimed at preventing or reducing distress or preventing some dreaded event or situation; however, these behaviors or mental acts either are not connected in a realistic way with what they are meant to neutralize or prevent or they are clearly excessive.
- At some point during the course of the disorder, the person recognizes that the obsessions or compulsions are excessive or unreasonable. This does not apply to children.
- The obsessions or compulsions cause marked distress; are time consuming (take >1 h/d); or significantly interfere with the person's normal routine, occupational or academic functioning, or usual social activities or relationships.
- If another Axis I disorder is present, the content of the obsessions or compulsions is not restricted to it, such as preoccupation with food and weight in the presence of an eating disorder, hair pulling in the presence of trichotillomania, concern with appearance in body dysmorphic disorder, preoccupation with drugs in substance use disorder, preoccupation with having a serious illness in hypochondriasis, preoccupation with sexual urges in paraphilia, or guilty ruminations in the presence of major depressive disorder.
- The disorder is not due to the direct physiologic effects of a substance or a general medical condition.
- The additional specification of "with poor insight" is made if, for most of the current episode, the person does not recognize that the symptoms are excessive or unreasonable.
Obsessions and their related compulsions (the latter also referred to as rituals) often fall into 1 or more of several common categories.
Table. Categorizing Obsessions and Compulsions
Open table in new window
Table
Obsessions | Commonly Associated Compulsions |
| Fear of contamination | Washing, cleaning |
| Need for symmetry, precise arranging | Ordering, arranging, balancing, straightening until "just right" |
| Unwanted sexual or aggressive thoughts or images | Checking, praying, “undoing” actions, asking for reassurance |
| Doubts (eg, gas jets off, doors locked) | Repeated checking behaviors |
| Concerns about throwing away something valuable | Hoarding |
Obsessions | Commonly Associated Compulsions |
| Fear of contamination | Washing, cleaning |
| Need for symmetry, precise arranging | Ordering, arranging, balancing, straightening until "just right" |
| Unwanted sexual or aggressive thoughts or images | Checking, praying, “undoing” actions, asking for reassurance |
| Doubts (eg, gas jets off, doors locked) | Repeated checking behaviors |
| Concerns about throwing away something valuable | Hoarding |
Individuals often have obsessions and compulsions in several categories, and may have other obsessions (eg, scrupulosity, somatic obsessions, physical or mental repeating rituals). Often, the first pathological obsession that an individual may experience is fear of contamination.
OCD should not be confused with obsessive-compulsive personality disorder (OCPD). The diagnosis of OCPD refers to an individual who has "a pervasive pattern of preoccupation with orderliness, perfectionism, and mental and interpersonal control, at the expense of flexibility, openness, and efficiency, beginning by early adulthood." They often display perfectionism, excessive devotion to work, rigidity, and/or miserliness (for further details, see DSM-IV-TR).1 Lay individuals may often describe an individual with such a personality as having OCD, but, just as lay individuals may describe someone who appears to have characteristics of multiple personalities as schizophrenic, this is also quite inaccurate. In fact, despite the unfortunate similarities in labels, relatively few individuals with OCD also meet criteria for OCPD, and the converse is also true.
Although OCD is categorized as an anxiety disorder in DSM-IV-TR, Dr. Eric Hollander has proposed that it should instead be considered an impulse control disorder along with other disorders such as trichotillomania, kleptomania, and pathological gambling, which would comprise an O-C spectrum of disorders2,3 , although this remains a controversial proposal4 .
Case vignette
Ms. A is a 32-year old married mother of 2, living with her family in a suburban community. She comes to a psychiatrist’s office seeking help, with the strong encouragement of her husband, stating that she “just can’t cope anymore.”
In recent years, she has been spending increasing amounts of time, now at least 4 hours per day, in cleaning rituals. She will not allow anyone in the house to wear shoes, has declared the upstairs bathroom off limits, and will not let anyone else in the kitchen. She washes her hands with hot water and soap for at least 5 minutes after any occasion when she feels they have been contaminated and always wears gloves when outside. The skin on her hands is reddened and irritated. She spends up to an hour a day keeping items in the house in perfect placement (symmetrical and balanced), and she can become extremely angry if someone disturbs their placement. She spends approximately an hour every day arranging and rearranging her clothes in her closets, ordering each item on hangers in placement by size and color and correcting anything that is not hanging exactly symmetrically.
Over the last year she has also become phobic when seeing or hearing words pertaining to death, fearing that this could somehow lead to an untimely death for one of her children. If she reads such words or hears them on the radio or television, she will repeat the Lord’s Prayer in her own mind 100 times; if she loses count she will start again. This has led to her general avoidance of reading and listening to radio or television, except at times when she feels the content will be “safe.”
Initially rather clean, neat, fastidious, and cautious, these potentially adaptive tendencies have grown very trying for her husband and 2 young children, and an inordinate amount of time and attention is taken up related to her perceived needs for rules for cleaning and household items to be arranged “just so.” She recognizes the craziness of her fears of the word "death," but feels she cannot control her responses. She has become frustrated and unhappy coping with her fears and her burdensome responses, and although very reluctant to give up any of her protective rituals, she has agreed to seek professional advice, with the urging of an aunt who has confided her own successful struggles with similar problems.
Pathophysiology
The exact pathophysiologic process that underlies OCD has not been established. Research and treatment trials suggest that abnormalities in serotonin (5-HT) neurotransmission in the brain are meaningfully involved in this disorder. This is strongly supported by the efficacy of serotonin reuptake inhibitors (SRIs) in the treatment of OCD.5,6
Evidence also suggests abnormalities in dopaminergic transmission in at least some cases of OCD. In some cohorts, Tourette disorder (also known as Tourette syndrome) and multiple chronic tics genetically co-vary with OCD in an autosomal dominant pattern. OCD symptoms in this group of patients show a preferential response to a combination of serotonin specific reuptake inhibitors (SSRIs) and antipsychotics.7
Functional imaging studies in OCD have demonstrated some reproducible patterns of abnormality. Specifically, MRI and positron emission tomography (PET) scanning have shown increases in blood flow and metabolic activity in the orbitofrontal cortex, limbic structures, caudate, and thalamus, with a trend toward right-sided predominance. In some studies, these areas of overactivity have been shown to normalize following successful treatment with either SSRIs or cognitive-behavioral therapy (CBT).8 These findings suggest the hypothesis that the symptoms of OCD are driven by impaired intracortical inhibition of specific orbitofrontal-subcortical circuitry that mediates strong emotions and the autonomic responses to those emotions. Cingulotomy, a neurosurgical intervention sometimes used for severe and treatment-resistant OCD, interrupts this circuit (see Treatment).
Similar abnormalities of inhibition are observed in Tourette disorder, with a postulated abnormal modulation of basal ganglia activation.
More recently, attention has focused on glutamatergic abnormalities and possible glutamatergic treatments for OCD.9 Although modulated by serotonin and other neurotransmitters, the synapses in the cortico-striato-thalamo-cortical circuits thought to be centrally involved in the pathology of OCD principally employ the neurotransmitters glutamate and gamma-aminobutyric acid (GABA). Preclinical studies and several case reports and small clinical trials have provided some preliminary support for the therapeutic use of specific glutamatergic agents.10,11 However, these agents (eg, memantine, N-acetylcysteine, riluzole, topiramate, glycine) have varied glutamatergic and other pharmacological effects, so if they are demonstrated to be effective, clarifying any therapeutic mechanism of action will be important.
The fact that obsessive-compulsive symptoms seem to often take very stereotypic forms has led some to hypothesize that the pathological disturbance causing OCD may be disinhibiting and exaggerating some built-in behavioral potential that we have, which under other circumstances might have an adaptive function (eg, primate grooming rituals).
Frequency
United States
Once believed to be rare, OCD was found to have a lifetime prevalence of 2.5% in the Epidemiological Catchment Area study.12 Current estimates of lifetime prevalence are generally in the range of 1.7-4%. Discovery of effective treatments and education of patients and health care providers have significantly increased the identification of individuals with OCD over the past decade.
International
International studies have shown a similar incidence and prevalence of OCD worldwide.
Mortality/Morbidity
- OCD is a chronic disorder. Without treatment, symptoms may wax and wane in intensity but rarely remit spontaneously. While many patients experience moderate symptoms, OCD can be a severe and disabling illness.
- Those with OCD often do not seek treatment. Many individuals with OCD delay for years before obtaining an evaluation for obsessive-compulsive (OC) symptoms. Patients with OCD often feel shame regarding their symptoms and put great effort into concealing them from family, friends, and health care providers.
Race
OCD appears to have a similar prevalence in different races and ethnicities, although specific pathological preoccupations may vary with culture and religion (eg, concerns about blaspheming are more common in religious Catholics and Orthodox Jews).
Sex
The overall prevalence of OCD is equal in males and females, although the disorder more commonly presents in males in childhood or adolescence, and in females in their twenties. Childhood-onset OCD is more common in males and more likely to be comorbid with attention deficit hyperactivity disorder (ADHD) and Tourette disorder.
It is not uncommon for women to experience the onset of OCD during a pregnancy, although those who already have OCD will not necessarily experience worsening of their symptoms during pregnancy. However, women commonly experience worsening of their OCD symptoms during the premenstrual time of their periods. Women who are pregnant or breastfeeding should collaborate with their physicians in making decisions about starting or continuing OCD medications.
Age
Symptoms usually begin in individuals aged 10-24 years. Childhood-onset OCD may have a higher rate of comorbidity with Tourette Disorder and ADHD.
Clinical
History
OCD is diagnosed primarily by presentation and history. Once the diagnosis is suspected, the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)13 is an important tool in defining the range and severity of symptoms and monitoring the response to treatment. The Y-BOCS is comprised of 10 items, 5 for obsessions and 5 for compulsions, each scored 0-4 (total score 0-40). For both obsessions and compulsions, these items rate the time spent, interference with functioning, distress, resistance, and control. Elements that should be covered when obtaining the history, including suggestions for typical interview questions, include the following:14
- Nature and severity of obsessive symptoms
- Have you ever been bothered by thoughts that do not make any sense and keep coming back to you even when you try not to have them?
- When you had these thoughts, did you try to get them out of your head? What would you try to do?
- Where do you think these thoughts were coming from?
- Nature and severity of compulsive symptoms
- Has there ever been anything that you had to do over and over again and could not resist doing, such as repeatedly washing your hands, counting up to a certain number, or checking something several times to make sure you have done it right?
- What behavior did you have to do?
- Why did you have to do the repetitive behavior?
- How many times would you do it and how long would it take?
- Do these thoughts or actions take more time than you think makes sense?
- What effect do they have on your life?
Information appropriate for a full evaluation is as follows:
- Age of onset
- History of tics, either current or past
- Psychiatric review of systems and comorbidities
- OCD is frequently attended by other psychiatric comorbid diagnoses, prominently including major depressive disorder, alcohol and/or substance use disorders, other anxiety disorders, impulse control disorders (eg, trichotillomania, skin-picking), and Tourette and tic disorders (perhaps 40% of individuals with Tourette disorder will have OCD). Therefore, in taking a psychiatric history, the focus should be on identifying such comorbidities, seeking to elicit the following:
- Mood and anxiety symptoms
- Somatoform disorders, especially hypochondriasis and body dysmorphic disorder
- Eating disorders
- Impulse control disorders, especially kleptomania and trichotillomania
- ADHD
- The co-occurrence of schizophrenia and OCD is more problematic for a variety of reasons. Not infrequently, individuals with schizophrenia do seem to have significant OC symptoms (sometimes, ironically, caused or exacerbated by the use of the very effective antipsychotic clozapine, whereas adjunctive antipsychotics may lessen treatment-resistant OC symptoms in those who do not have schizophrenia). When OC symptoms are present in someone who has schizophrenia, they may meet criteria for a diagnosis of OCD, but such patients often respond poorly to the usual OCD treatments, and perhaps OCD in schizophrenia has a different pathophysiology.
- Family history of OCD, Tourette disorder, tics, ADHD, and other psychiatric diagnose
- Current or past substance abuse or dependence
- Antecedent infections, especially streptococcal and herpetic infection
- Common obsessions include the following:
- Contamination
- Safety
- Doubting one's memory or perception
- Scrupulosity (need to do the right thing, fear of committing a transgression, often religious)
- Need for order or symmetry
- Unwanted, intrusive sexual/aggressive thought
- Common compulsions include the following:
- Cleaning/washing
- Checking (checking locks, stove, iron, safety of children)
- Counting/repeating actions a certain number of times or until it "feels right"
- Arranging objects
- Touching/tapping objects
- Hoarding
- Confessing/seeking reassurance
- List making
- OCD is frequently attended by other psychiatric comorbid diagnoses, prominently including major depressive disorder, alcohol and/or substance use disorders, other anxiety disorders, impulse control disorders (eg, trichotillomania, skin-picking), and Tourette and tic disorders (perhaps 40% of individuals with Tourette disorder will have OCD). Therefore, in taking a psychiatric history, the focus should be on identifying such comorbidities, seeking to elicit the following:
Physical
- A complete Mental Status Examination should be performed. The patient should be evaluated for orientation, memory, disturbances of mood and affect, presence of hallucinations, delusions, suicidal and homicidal risk, and judgment (including whether insight into the irrational nature of their symptoms is still present).
- Evaluate all patients with OCD for the presence of Tourette disorder or other tic disorders, as these comorbid diagnoses may influence treatment strategy. The findings on neurologic and cognitive examination should otherwise be normal. Focal neurologic signs or evidence of cognitive impairment should prompt evaluation for other diagnoses.
- Skin findings in OCD may include the following:
- Eczematous eruptions related to excessive washing
- Hair loss related to trichotillomania or compulsive hair pulling
- Excoriations related to neurodermatitis or compulsive skin picking
Causes
The cause of OCD is not known; however, the following factors are relevant:
- Genetic: Twin studies have supported strong heritability for OCD, with a genetic influence of 45-65% in studies in children, and 27-47% in adults.15 Monozygotic twins may be strikingly concordant for OCD (80-87%), compared with 47-50% concordance in dizygotic twins.16 Several genetic studies have supported linkages to a variety of serotonergic, dopaminergic, and glutamatergic genes.17,18,19,20,21 Other genes putatively linked to OCD have included those coding for catechol-O-methyltransferase (COMT), monoamine oxidase-A (MAO-A), brain-derived neurotrophic factor (BDNF), myelin oligodendrocyte glycoprotein (MOG), GABA-type B-receptor 1, and the mu opioid receptor, but these must be considered provisional associations at this time. In some cohorts, OCD, ADHD, and Tourette disorder/tic disorders co-vary in an autosomal dominant fashion with variable penetrance.
- Infectious: Case reports have been published of OCD with and without tics arising in children and young adults following acute group A streptococcal infections. Fewer reports cite herpes simplex virus as the apparent precipitating infectious event. It has been hypothesized that these infections trigger a CNS autoimmune response that results in neuropsychiatric symptoms (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections [PANDAS]). A number of the poststreptococcal cases have reportedly improved following treatment with antibiotics.
- Other neurological conditions: Rare reports exist of OCD presenting as a manifestation of neurologic insults such as brain trauma, stimulant abuse, carbon monoxide poisoning.
- Stress: OCD symptoms can worsen with stress; however, stress does not appear to be an etiologic factor.
- Interpersonal relationships
- OCD symptoms can interact negatively with interpersonal relationships, and families can become involved with the illness in a counterproductive way (eg, a patient with severe doubting obsessions may constantly ask reassurance for irrational fears from family members or significant others; constantly providing this can inhibit the patient from making attempts to work on their behavioral disturbances).
- Parenting style or upbringing does not appear to be a causative factor in OCD.
More on Obsessive-Compulsive Disorder |
Overview: Obsessive-Compulsive Disorder |
| Differential Diagnoses & Workup: Obsessive-Compulsive Disorder |
| Treatment & Medication: Obsessive-Compulsive Disorder |
| Follow-up: Obsessive-Compulsive Disorder |
| References |
| Next Page » |
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
Bartz J, Hollander E. Is obsessive-compulsve disorder an anxiety disorder?. Prog Neuropsychopharmacol Biol Psychiatry. May 2006;30:338-352. [Medline].
Dell'Osso B, Altamura AC, Allen A, Marazziti D, Hollander E. Epidemiologic and clinical updates on impulse control disorders: a critical review. Eur Arch Psychiatry Clin Neurosci. December 2006;256:464-475. [Medline].
Castle DJ, Phillips KA. Obsessive-compulsive spectrum of disorders: a defensible construct?. Aust N Z J Psychiatry. February 2006;40:114-120. [Medline].
Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis. Arch Gen Psychiatry. Jan 1995;52(1):53-60. [Medline].
Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ. Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psychopharmacology. April, 1998;136:205-216. [Medline].
Bloch MH, Landeros-Weisenberger A, Klemendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. July 2006;11:622-632. [Medline].
Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate change with both drug and behavior therapy for OCD. Arch Gen Psychiatry. 1992;49:681-689. [Medline].
Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx. January 2006;3:69-81. [Medline].
Coric V, Taskiran S, Pittenger C, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. September 2005;58:424-428. [Medline].
Greenberg WM, Benedict MM, Doerfer J, Perrin M, Panek L, Cleveland WL. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults. J Psychiatr Res. Nov 29 2008;[Medline].
Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. December 1988;45:1094-1099. [Medline].
Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. Nov 1989;46(11):1006-11. [Medline].
First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID-I/P, 11/2002 revision). New York: Biometrics Research Department, New York State Psychiatric Institute; November 2002.
van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet. October 2005;8:450-458. [Medline].
Carey G, Gottesman I. Twin and family studies of anxiety, phobic, and obsessive disorders. In: Klein DF, Rabkin JG. Anxiety: New Research and Changing Concepts. New York: Raven Press; 2000.
Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obessive-compulsive disorder: a preliminary study. Psychopharmacology. August 2004;174:530-538. [Medline].
Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. July 2006;63:769-776. [Medline].
Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H. Association between the dopamine D2 receptor TAQI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol. August 2006;16:446-450. [Medline].
Dickel DE, Veenstra-VanderWeele J, Cox NJ, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry. July 2006;63:778-785. [Medline].
Lin P-Y. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. April 2007;31:683-689. [Medline].
[Guideline] American Psychiatric Association Work Group on Obsessive-Compulsive Disorder. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. July 2007;164(suppl):1-56. [Full Text].
Foa EB, Wilson R. Stop Obsessing!: How to Overcome Your Obsessions and Compulsions. Revis ed. New York: Bantam Dell; 2001.
Grayson J. Freedom From Obsessive Compulsive Disorder: A Personalized Recovery Program for Living With Uncertainty. New York: Berkley Publishing Group; 2004.
Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. November 2006;31:2384-2393. [Medline].
Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. Nov 13 2008;359(20):2121-34. [Medline].
Jung HH, Kim CH, Chang JH, Park YG, Chung SS, Chang JW. Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder: long-term follow-up results. Stereotact Funct Neurosurg. 2006;84:184-189. [Medline].
FDA Public Health Advisory: Suicidality in Children and Adolescents Being Treated With Antidepressant Medications: October 15, 2004. FDA Website: FDA; October 15, 2004. 1-3. [Full Text].
FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications. FDA Website: FDA; May 2, 2007. 1-3. [Full Text].
Rapoport JL. The Boy Who Couldn't Stop Washing: The Experience and Treatment of Obsessive-Compulsive Disorder. paperback. New York: Penguin Putnam; 2001.
Austin LS, Lydiard RB, Fossey MD, et al. Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry. Nov 1990;51(11):456-8. [Medline].
Baer L, Rauch SL, Ballantine HT Jr, et al. Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients. Arch Gen Psychiatry. May 1995;52(5):384-92. [Medline].
Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. Jul 1996;53(7):595-606. [Medline].
Eddy MF, Walbroehl GS. Recognition and treatment of obsessive-compulsive disorder. Am Fam Physician. Apr 1 1998;57(7):1623-8, 1632-4. [Medline].
Geller DA, Biederman J, Jones J, et al. Obsessive-compulsive disorder in children and adolescents: a review. Harv Rev Psychiatry. Jan-Feb 1998;5(5):260-73. [Medline].
Goodman WK. Obsessive-compulsive disorder: diagnosis and treatment. J Clin Psychiatry. 1999;60 Suppl 18:27-32. [Medline].
Goodman WK, McDougle CJ, Barr LC, et al. Biological approaches to treatment-resistant obsessive compulsive disorder. J Clin Psychiatry. Jun 1993;54 Suppl:16-26. [Medline].
Goodman WK, McDougle CJ, Price LH. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder. Int Clin Psychopharmacol. Jun 1992;7 Suppl 1:35-8. [Medline].
Goodman WK, Price LH, Delgado PL, et al. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry. Jun 1990;47(6):577-85. [Medline].
Grachev ID, Breiter HC, Rauch SL, et al. Structural abnormalities of frontal neocortex in obsessive-compulsive disorder. Arch Gen Psychiatry. Feb 1998;55(2):181-2. [Medline].
Greenberg BD, Ziemann U, Harmon A, et al. Decreased neuronal inhibition in cerebral cortex in obsessive- compulsive disorder on transcranial magnetic stimulation. Lancet. Sep 12 1998;352(9131):881-2. [Medline].
Greist JH, Jefferson JW. Pharmacotherapy for obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):64-70. [Medline].
Hollander E, Cohen LJ. The assessment and treatment of refractory anxiety. J Clin Psychiatry. Feb 1994;55 Suppl:27-31. [Medline].
Jenike MA. Clinical Practice: Obsessive-Compulsive Disorder. N Engl J Med. Jan 15, 2004;350:259-265. [Medline].
Leckman JF, Grice DE, Barr LC, et al. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety. 1994-95;1(5):208-15. [Medline].
Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry. Apr 1992;53 Suppl:4-10. [Medline].
Samuels J, Nestadt G. Epidemiology and genetics of OCD. International Review of Psychiatry. 1997;9(1):61-72.
Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry. 1998;173(suppl 35):26-37. [Medline].
Schwartz JM, Stoessel PW, Baxter LR Jr, et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. Feb 1996;53(2):109-13. [Medline].
Sheppard DM, Bradshaw JL, Purcell R, Pantelis C. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?. Clin Psychol Rev. Aug 1999;19(5):531-52. [Medline].
Further Reading
Keywords
OCD, obsessive-compulsive disorder, obsessions, anxiety, obsessive compulsive disorder treatment, symptoms, cognitive-behavioral therapy, CBT, anxiety, behavior therapy, exposure and response prevention
Overview: Obsessive-Compulsive Disorder